Two U.S. senators launched a bipartisan investigation into rising insulin prices on Feb. 22, sending letters to the drug's top three manufacturers seeking information about why costs have risen so sharply in recent years.

Cardiologists are moderately happy at work compared to other specialists, according to Medscape’s Cardiologist Lifestyle, Happiness & Burnout Report 2019, but they’re still experiencing burnout at record rates.

Patients with coronary artery disease (CAD) enrolled in private insurance plans through Medicare Advantage (MA) are more likely to receive guideline-recommended medications for secondary prevention than those in fee-for-service Medicare, according to a new analysis in JAMA Cardiology. But that wasn't tied to improvements in blood pressure or cholesterol levels.

The ultra-thin Orsiro drug-eluting stent (DES) has received FDA approval and is now commercially available in the United States, device manufacturer Biotronik announced Feb. 22.

A nurse navigator-led program at Providence St. Vincent Medical Center in Oregon helped the hospital double its palliative care referral rates for advanced heart failure patients considered to be at high risk of readmission.

A national cardiovascular disease screening project in China revealed fewer than 3 percent of high-risk participants were taking either statins or aspirin—a finding researchers described as a “wake-up call” for middle- and low-income countries which are struggling to combat their worsening CVD risk profiles.

A study published in the February issue of the Journal of the National Comprehensive Cancer Network found cancer patients who are dually diagnosed with heart disease face a disproportionately high financial burden—something that might improve with a more streamlined and collaborative approach to cardio-oncology.

An analysis of sex-related differences in cardiovascular risk factors, treatment and control in the U.S. has revealed women have a better handle on their high blood pressure than men, but they also fare worse in terms of cholesterol and obesity.

Oregon Health & Sciences University might have a chance to revive the heart transplant program it shuttered last August after all four of its cardiologists left the institution, according to reports from the Oregonian and Oregon Live.

T2 mapping derived from weekly cardiac MRIs helped researchers identify cardiotoxicity at an early and reversible stage, a finding which may have implications for cancer patients at risk of chemotherapy-induced heart failure.

Diabetes mellitus continues to be linked to higher all-cause and CVD mortality in patients living with the disease, according to work published in the Journal of the American Heart Association Feb. 19. But some of that risk could be mitigated by controlling cardiovascular risk factors, and diabetes-related deaths are down overall.

The Department of Energy’s National Nuclear Security Administration (NNSA) will negotiate with four U.S. companies to potentially fund molybdenum-99 (Mo-99) production without the use of highly enriched uranium.